STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 65 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q1 2018. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $6,000 | -80.6% | 2,937 | -72.2% | 0.00% | – |
| Q2 2021 | $31,000 | +121.4% | 10,559 | +105.7% | 0.00% | – |
| Q1 2021 | $14,000 | +27.3% | 5,132 | +15.0% | 0.00% | – |
| Q4 2020 | $11,000 | – | 4,461 | +9813.3% | 0.00% | – |
| Q3 2020 | $0 | – | 45 | -27.4% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 62 | -96.2% | 0.00% | – |
| Q1 2020 | $3,000 | -66.7% | 1,612 | -61.7% | 0.00% | – |
| Q4 2019 | $9,000 | +350.0% | 4,210 | +341.3% | 0.00% | – |
| Q3 2019 | $2,000 | -50.0% | 954 | -27.8% | 0.00% | – |
| Q2 2019 | $4,000 | -20.0% | 1,321 | +45.3% | 0.00% | – |
| Q1 2019 | $5,000 | – | 909 | +18080.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 5 | -96.9% | 0.00% | – |
| Q4 2017 | $1,000 | -92.9% | 159 | -91.9% | 0.00% | – |
| Q3 2017 | $14,000 | +1300.0% | 1,971 | +2563.5% | 0.00% | – |
| Q2 2017 | $1,000 | – | 74 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 978,907 | $6,865,000 | 3.28% |
| RA Capital Management | 2,690,702 | $20,449,000 | 2.02% |
| NEA Management Company, LLC | 2,141,308 | $16,274,000 | 1.04% |
| Broadfin Capital, LLC | 1,656,705 | $10,911,000 | 0.67% |
| Tredje AP-fonden | 909,581 | $6,913,000 | 0.44% |
| Granite Point Capital Management, L.P. | 388,945 | $2,679,000 | 0.40% |
| Ghost Tree Capital, LLC | 72,726 | $553,000 | 0.23% |
| SPHERA FUNDS MANAGEMENT LTD. | 181,818 | $1,382,000 | 0.20% |
| Tower Research Capital LLC (TRC) | 1,094 | $8,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 1,373 | $10,000 | 0.00% |